Status:
UNKNOWN
VolumE maNagement Under Body Composition Monitoring in Critically Ill patientS on CRRT
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Seoul National University Bundang Hospital
SMG-SNU Boramae Medical Center
Conditions:
Renal Dialysis
Fluid Overload
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Although monitoring fluid balance for continuous renal replacement therapy-treated patients is an important issue, most physicians usually use conventional methods such as the difference between the a...
Detailed Description
Although monitoring fluid balance for continuous renal replacement therapy-treated patients is an important issue, most physicians usually use conventional methods such as the difference between the a...
Eligibility Criteria
Inclusion
- Patients will be eligible for INCLUSION in the study if ALL the following criteria are met;
- The treating clinician believes that the patient requires continuous renal replacement therapy for acute renal failure.
- The treating clinicians anticipate treating the patient with continuous renal replacement therapy for at least 72 hours.
- Informed consent has been obtained.
- The patient fulfills ONE of the following clinical criteria for initiating continuous renal replacement therapy:
- urine output \< 100 ml/6 hr that has been unresponsive to fluid resuscitation measures
- K+\> 6.5 mmol/L
- pH \< 7.2
- Urea \> 25 mmol/L
- Clinically significant organ edema in the setting of acute kidney injury
- Patients who are over 5% of fluid overload or their total body water/height\^2 ≥13 L/m\^2
Exclusion
- Patients will be EXCLUDED from the study if, in the opinion or knowledge of the responsible clinician ANY of the following criteria are present:
- Patient age is \< 18 years
- Death is imminent (\<24 hours)
- There is a strong likelihood that the study treatment will not be continued in accordance with the study protocol.
- The patient has been treated with continuous renal replacement therapy or other dialysis previously during the same hospital admission.
- The patient has been on maintenance dialysis prior to the current hospitalization.
- Any other major illness that, in the investigator's judgement, will substantially increase the risk associated with the subject's participation in this study.
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
244 Patients enrolled
Trial Details
Trial ID
NCT03330626
Start Date
July 1 2017
End Date
December 31 2019
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bundang Seoul National University Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620